Home/Filings/4/0001104659-20-089140
4//SEC Filing

Talbot George Harrison 4

Accession 0001104659-20-089140

CIK 0001641640other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 4:54 PM ET

Size

7.3 KB

Accession

0001104659-20-089140

Insider Transaction Report

Form 4
Period: 2020-07-29
Transactions
  • Award

    Ordinary Shares

    2020-07-29+17,50065,140 total
  • Award

    Stock Options

    2020-07-29+35,00035,000 total
    Exercise: $0.79Exp: 2030-07-28Ordinary Shares (35,000 underlying)
Footnotes (3)
  • [F1]The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
  • [F2]The option was granted on July 29, 2020.
  • [F3]One hundred percent (100%) of the option will vest on July 31, 2021, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001554194

Filing Metadata

Form type
4
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:54 PM ET
Size
7.3 KB